Long-term adverse outcomes associated with antenatal exposure to drugs
Research type
Research Study
Full title
Investigating long term adverse outcomes associated with antenatal exposure to anti-hypertensive, asthma, and psychotropic medications.
IRAS ID
201266
Contact name
James McLay
Contact email
Sponsor organisation
University of Aberdeen
Duration of Study in the UK
2 years, 11 months, 31 days
Research summary
This study is making use of routinely collected data to identify possible long term consequences in the offspring of mothers, who have used certain medications during pregnancy. The drugs of interest are anti-hypertensives, asthma therapies, or psychotropic drugs taken by pregnant women for the treatment of an underlying medical condition. The outcomes are measured in neonates, infants, and children and will be identified using routine NHS healthcare databases. The study will possibly identify hitherto unexpected long term consequences for children that will be the focus for further study.
REC name
North West - Greater Manchester South Research Ethics Committee
REC reference
16/NW/0313
Date of REC Opinion
20 Apr 2016
REC opinion
Favourable Opinion